$IRBT
IROBOT CORP Stock $irbt

$irbt Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000115916721000008 Filed on February 16, 2021

Income Statement

Concept	2021 Q1	2019 Q4	2019 Q3
Revenue	$544.8M	$426.8M	$289.4M
YoY Change	182.96%	10.95%	9.4%
Cost Of Revenue	$329.4M	$257.4M	$152.6M
YoY Change	187.48%	29.87%	17.96%
Gross Profit	$215.4M	$169.4M	$136.8M
YoY Change	176.31%	-9.19%	1.21%
Gross Profit Margin	39.54%	39.69%	47.28%
Selling, General & Admin	$155.2M	$115.3M	$60.63M
YoY Change	153.73%	-3.11%	-2.77%
% of Gross Profit	72.05%	68.08%	44.31%
Research & Development	$44.70M	$37.30M	$33.40M
YoY Change	21.6%	-0.53%	-5.4%
% of Gross Profit	20.75%	22.02%	24.41%
Depreciation & Amortization	$9.100M	$9.500M	$9.800M
YoY Change	22.0%	-1.04%	5.38%
% of Gross Profit	4.22%	5.61%	7.16%
Operating Expenses	$200.2M	$152.8M	$94.29M
YoY Change	103.91%	-2.49%	-3.72%
Operating Profit	$15.20M	$16.57M	$42.56M
YoY Change	-175.15%	-44.42%	14.16%
Interest Expense		-$100.0K	$900.0K
YoY Change		-116.67%	125.0%
% of Operating Profit		-0.6%	2.11%
Other Income/Expense, Net	-$200.0K	$8.600M	$900.0K
YoY Change	952.63%	-4400.0%	167.06%
Pretax Income	$15.00M	$25.10M	$43.46M
YoY Change	-174.1%	-16.89%	15.53%
Income Tax	$1.700M	$5.000M	$7.923M
% Of Pretax Income	11.33%	19.92%	18.23%
Net Earnings	$13.30M	$20.04M	$35.53M
YoY Change	-173.34%	-20.44%	11.28%
Net Earnings / Revenue	2.44%	4.7%	12.28%
Basic Earnings Per Share			$1.26
Diluted Earnings Per Share	$458.6K	$0.70	$1.24
COMMON SHARES
Basic Shares Outstanding	28.20M shares	28.27M shares	28.15M shares
Diluted Shares Outstanding			28.65M shares

Balance Sheet

Concept	2021 Q1	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$483.7M	$256.4M	$91.10M
YoY Change	83.57%	58.27%	-32.57%
Cash & Equivalents	$432.6M	$239.4M	$70.54M
Short-Term Investments	$51.10M	$17.00M	$20.50M
Other Short-Term Assets	$45.22M	$34.29M	$39.11M
YoY Change	8.34%	33.61%	7.65%
Inventory	$181.8M	$157.3M	$248.3M
Prepaid Expenses
Receivables	$170.5M	$146.2M	$169.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$881.2M	$594.2M	$548.0M
YoY Change	80.01%	15.51%	24.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$76.58M	$75.99M	$75.02M
YoY Change	-3.7%	33.25%	38.42%
Goodwill	$125.9M	$118.7M	$117.5M
YoY Change	6.33%	-0.14%	-1.07%
Intangibles	$9.902M	$12.35M
YoY Change
Long-Term Investments	$17.40M	$21.00M	$22.40M
YoY Change	-18.31%	39.07%	43.59%
Other Assets	$19.06M	$30.20M	$32.00M
YoY Change	-43.56%	96.71%	104.53%
Total Long-Term Assets	$308.5M	$326.5M	$325.6M
YoY Change	-6.65%	29.31%	30.34%
TOTAL ASSETS
Total Short-Term Assets	$881.2M	$594.2M	$548.0M
Total Long-Term Assets	$308.5M	$326.5M	$325.6M
Total Assets	$1.190B	$920.8M	$873.7M
YoY Change	45.08%	20.05%	26.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$165.8M	$116.2M	$108.3M
YoY Change	114.69%	-15.03%	5.03%
Accrued Expenses	$131.4M	$81.77M	$70.59M
YoY Change	135.46%	14.75%	12.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$307.6M	$202.5M	$183.8M
YoY Change	122.33%	-5.27%	7.68%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$26.54M	$10.34M	$9.059M
YoY Change	139.98%	-25.47%	-21.85%
Total Long-Term Liabilities	$77.73M	$66.18M	$66.96M
YoY Change	19.29%	270.1%	286.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$307.6M	$202.5M	$183.8M
Total Long-Term Liabilities	$77.73M	$66.18M	$66.96M
Total Liabilities	$385.3M	$268.7M	$250.8M
YoY Change	89.34%	15.99%	33.38%
SHAREHOLDERS EQUITY
Retained Earnings	$599.4M	$452.3M	$432.3M
YoY Change	38.05%	23.24%	26.46%
Common Stock	$205.5M	$196.7M	$189.6M
YoY Change	16.74%	13.69%	15.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$804.4M	$652.1M	$622.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.190B	$920.8M	$873.7M
YoY Change	45.08%	20.05%	26.32%

Cashflow Statement

Concept	2021 Q1	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	$13.30M	$20.04M	$35.53M
YoY Change	-173.34%	-20.44%	11.28%
Depreciation, Depletion And Amortization	$9.100M	$9.500M	$9.800M
YoY Change	22.0%	-1.04%	5.38%
Cash From Operating Activities	$135.3M	$161.7M	-$52.90M
YoY Change	232.15%	414.97%	-477.86%
INVESTING ACTIVITIES
Capital Expenditures	-$6.600M	-$8.200M	-$12.40M
YoY Change	-190.29%	15.49%	12.73%
Acquisitions
YoY Change
Other Investing Activities	$2.600M	$13.20M	$2.700M
YoY Change	66.67%	288.24%	-18.18%
Cash From Investing Activities	-$3.900M	$5.000M	-$9.700M
YoY Change	-27.37%	-231.58%	25.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.500M	2.200M	300.0K
YoY Change	-105.8%	-8.33%	-94.34%
NET CHANGE
Cash From Operating Activities	135.3M	161.7M	-52.90M
Cash From Investing Activities	-3.900M	5.000M	-9.700M
Cash From Financing Activities	1.500M	2.200M	300.0K
Net Change In Cash	132.9M	168.9M	-62.30M
YoY Change	1317.45%	463.0%	-637.07%
FREE CASH FLOW
Cash From Operating Activities	$135.3M	$161.7M	-$52.90M
Capital Expenditures	-$6.600M	-$8.200M	-$12.40M
Free Cash Flow	$141.9M	$169.9M	-$40.50M
YoY Change	324.55%	341.3%	-262.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001159167
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-02
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28183668	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28352390	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28183668	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28352390	shares
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:AccruedLiabilitiesCurrent
CY2021Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:AccruedLiabilitiesCurrent
CY2021	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	at either (1) LIBOR plus a margin, currently equal to 1.0%, based on the Company's ratio of indebtedness to Adjusted EBITDA (the "Eurodollar Rate"), or (2) the lender's base rate.
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-01-02
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-36414
CY2021	dei	Entity Registrant Name EntityRegistrantName	iROBOT CORPORATION
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0259335
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 Crosby Drive
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Bedford
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01730
CY2021	dei	City Area Code CityAreaCode	781
CY2021	dei	Local Phone Number LocalPhoneNumber	430-3000
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2021	dei	Trading Symbol TradingSymbol	IRBT
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Public Float EntityPublicFloat	2300000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28199143	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432635000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239392000	USD
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	51081000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	17032000	USD
CY2021Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	170526000	USD
CY2021Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	170526000	USD
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	146161000	USD
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	146161000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	181756000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	157347000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	45223000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34285000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	881221000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	594217000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76584000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75988000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43682000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	47478000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	33404000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	41791000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	125872000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	118732000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9902000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12352000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19063000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30195000	USD
CY2021Q1	us-gaap	Assets Assets	1189728000	USD
CY2019Q4	us-gaap	Assets Assets	920753000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	165779000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	116185000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	131388000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81768000	USD
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10400000	USD
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4549000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	307567000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	202502000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50485000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54928000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	705000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	912000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26537000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10342000	USD
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	77727000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	66182000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	385294000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	268684000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	282000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	284000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	205256000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	196455000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	599389000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	452321000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-493000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3009000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	804434000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	652069000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1189728000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	920753000	USD
CY2021	us-gaap	Revenues Revenues	1430390000	USD
CY2019	us-gaap	Revenues Revenues	1214010000	USD
CY2018	us-gaap	Revenues Revenues	1092584000	USD
CY2021	irbt	Costofproductrevenue Costofproductrevenue	758241000	USD
CY2019	irbt	Costofproductrevenue Costofproductrevenue	658362000	USD
CY2018	irbt	Costofproductrevenue Costofproductrevenue	518612000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1920000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	11721000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	18544000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	760161000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	670083000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	670083000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	537156000	USD
CY2021	us-gaap	Gross Profit GrossProfit	670229000	USD
CY2019	us-gaap	Gross Profit GrossProfit	543927000	USD
CY2018	us-gaap	Gross Profit GrossProfit	555428000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	156670000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	141607000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	140629000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	265475000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	231548000	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	210411000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	100770000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	83103000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	97501000	USD
CY2021	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	992000	USD
CY2019	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	1051000	USD
CY2018	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	1065000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	523907000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	457309000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	449606000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	146322000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	86618000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	105822000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	41593000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12215000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2800000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	187915000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	98833000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	108622000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40847000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13533000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20630000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147068000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	85300000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	87992000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.23
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.04
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.18
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.97
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.07
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28101000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28097000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27692000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28618000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28735000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28640000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147068000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	85300000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	87992000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	14045000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3435000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-5896000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-13932000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	12363000	USD
CY2018	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-327000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	3587000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	1418000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	499000	USD
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-28000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	247000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-18000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	143566000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	93057000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	81252000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	470327000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10366000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25804000	USD
CY2018	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	3532000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6740000	USD
CY2018	irbt	Adjustments To Additional Paid In Capital Directors Deferred Compensation AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation	65000	USD
CY2018	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	799000	shares
CY2018	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	50000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	87992000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	535322000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7147000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23744000	USD
CY2019	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	7277000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7757000	USD
CY2019	irbt	Adjustments To Additional Paid In Capital Directors Deferred Compensation AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation	76000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	85300000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	652069000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5584000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29975000	USD
CY2021	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	-1845000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3502000	USD
CY2021	irbt	Adjustments To Additional Paid In Capital Directors Deferred Compensation AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation	85000	USD
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	25000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147068000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	804434000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147068000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	85300000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	87992000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34762000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37159000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	36574000	USD
CY2021	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	43817000	USD
CY2019	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	8439000	USD
CY2018	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	29975000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	23744000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	25804000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-13837000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	11118000	USD
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	10848000	USD
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6467000	USD
CY2019	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	7267000	USD
CY2018	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1837000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21893000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13064000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23920000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24535000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7307000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58546000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15804000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3310000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8533000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48699000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-20536000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	22470000	USD
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	57289000	USD
CY2019	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-386000	USD
CY2018	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1145000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	232048000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	130052000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71685000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31599000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35337000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32422000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4150000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	5436000	USD
CY2018	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2363000	USD
CY2021	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	0	USD
CY2019	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	9787000	USD
CY2018	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	856000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2817000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	6438000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	13500000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	12880000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	14000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22249000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20923000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26367000	USD
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5584000	USD
CY2019	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	7147000	USD
CY2018	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	10366000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1845000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7277000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3532000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25000000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21261000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-130000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43166000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	4705000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	20000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-414000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	193243000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	109019000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1738000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	239392000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	130373000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	128635000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	432635000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	239392000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	130373000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	19929000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	22582000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	39517000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:3.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.062%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nature of the Business</span></td></tr></table>iRobot Corporation ("iRobot" or the "Company") designs and builds robots that empower people to do more. iRobot's consumer robots help people find smarter ways to clean and accomplish more in their daily lives. The Company's portfolio of floor cleaning robots features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. Leveraging this portfolio, our engineers are building an ecosystem of robots to help realize the smart home's potential. The Company’s revenue is primarily generated from product sales through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers and through value-added distributors and resellers worldwide.
CY2021	us-gaap	Fiscal Period FiscalPeriod	The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter. The fiscal year ended January 2, 2021 ("fiscal 2020") was a 53-week fiscal year. The fiscal years ended December 28, 2019 ("fiscal 2019") and December 29, 2018 ("fiscal 2018") were 52-week fiscal years.
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:5pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses. These estimates and judgments, include but are not limited to, revenue recognition, including performance obligations, variable consideration and other obligations such as product returns and incentives; allowance for credit losses; product warranties; valuation of goodwill and acquired intangible assets; valuation of non-marketable equity investments; evaluating loss contingencies; accounting for stock-based compensation including performance-based assessments; and accounting for income taxes and related valuation allowances. The Company bases these estimates and judgments on historical experience, market participant fair value considerations, projected future cash flows and various other factors that the Company believes are reasonable under the circumstances. Actual results may differ from the Company’s estimates.</span></div>As of January 2, 2021, the impact of the COVID-19 pandemic remains dynamic and the nature and extent of its full impact will depend on several factors, including but not limited to, the duration and severity of the pandemic, advances in treatment and prevention, as well as the macroeconomic impact resulting from global responses to slow the spread. As a result, certain of our estimates and assumptions, including the allowance for credit losses and the valuation of non-marketable equity securities, including our impairment assessment, require increased judgment and carry a higher degree of variability and volatility that could result in material changes to our estimates in future periods.
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432600000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239400000	USD
CY2021Q1	irbt	Short Term Investments Cost ShortTermInvestmentsCost	50076000	USD
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	51081000	USD
CY2019Q4	irbt	Short Term Investments Cost ShortTermInvestmentsCost	17016000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	17032000	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	3600000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4800000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1200000	USD
CY2020Q2	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	57000000.0	USD
CY2021	irbt	Recovery Of Import Duties RecoveryOfImportDuties	36500000	USD
CY2021	irbt	Proceeds From Recovery Of Import Duties ProceedsFromRecoveryOfImportDuties	47100000	USD
CY2021Q1	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	9900000	USD
CY2021Q1	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	9900000	USD
CY2021Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	17400000	USD
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	21000000.0	USD
CY2020Q3	irbt	Investment Owned Number Of Shares Received In Accordance With Acquisition Of Investment InvestmentOwnedNumberOfSharesReceivedInAccordanceWithAcquisitionOfInvestment	200000	shares
CY2020Q3	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	38600000	USD
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	4900000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Restricted EquitySecuritiesFvNiRestricted	47600000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	145200000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	125000000.0	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	114000000.0	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7600000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3800000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1100000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:5pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially expose the Company to concentrations of credit risk consist of accounts receivable and cash and cash equivalents. Management believes its credit policies are prudent and reflect normal industry terms and business risk. At January 2, 2021, one customer accounted for 17.6% of the Company's accounts receivable balance. At December 28, 2019, two customers accounted for a total of 26.6% of the Company's accounts receivable balance. For the fiscal years ended January 2, 2021, December 28, 2019, and December 29, 2018, there was one customer that accounted for 10% or more of total revenue, representing 22.7%, 21.3% and 17.3%, of the Company's total revenue, respectively.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash in bank deposit accounts and money market funds at high quality financial institutions. The individual balances, at times, may exceed federally insured limits. These deposits may be redeemed upon demand, and management believes that the financial institutions that hold the Company’s cash and cash equivalents are financially sound and, accordingly, minimal credit risk exists with respect to cash and cash equivalents.</span></div>
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147068000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	85300000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	87992000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28101000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28097000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27692000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	517000	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	638000	shares
CY2018	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	948000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28618000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28735000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28640000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.23
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.04
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.18
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.97
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.07
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0.0	shares
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	11500000	USD
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4000000.0	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17700000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6991000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5500000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	160012000	USD
CY2021Q1	irbt	Refundliabilityproductreturns Refundliabilityproductreturns	64300000	USD
CY2021Q1	irbt	Refundliabilityothercreditsandincentives Refundliabilityothercreditsandincentives	142200000	USD
CY2019Q4	irbt	Refundliabilityproductreturns Refundliabilityproductreturns	55200000	USD
CY2019Q4	irbt	Refundliabilityothercreditsandincentives Refundliabilityothercreditsandincentives	134000000.0	USD
CY2021	us-gaap	Revenues Revenues	1430390000	USD
CY2019	us-gaap	Revenues Revenues	1214010000	USD
CY2018	us-gaap	Revenues Revenues	1092584000	USD
CY2021Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	170526000	USD
CY2021Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	170526000	USD
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	146161000	USD
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	146161000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5800000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0356
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M18D
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	9363000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	8777000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	3583000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	4096000	USD
CY2021	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	12946000	USD
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	12873000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	9862000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	9540000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50485000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8633000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2310000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53227000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8226000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7647000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6590000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6612000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	28539000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	66247000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9447000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	56800000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6315000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6315000	USD
CY2019Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6800000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75988000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6500000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156766000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	83428000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80778000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76584000	USD
CY2021	us-gaap	Depreciation Depreciation	31900000	USD
CY2019	us-gaap	Depreciation Depreciation	24400000	USD
CY2018	us-gaap	Depreciation Depreciation	17000000.0	USD
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2100000	USD
CY2019	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1500000	USD
CY2018	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1200000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	118896000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2050000	USD
CY2019	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-2214000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	118732000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	7140000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	125872000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	74526000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	64624000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9902000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71231000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	58879000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12352000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2900000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12800000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19600000	USD
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1723000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1498000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	823000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	823000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	823000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4212000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9902000	USD
CY2021Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	31523000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	12541000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	24392000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	13856000	USD
CY2021Q1	irbt	Accrued Manufacturing And Logistics Costs AccruedManufacturingAndLogisticsCosts	20093000	USD
CY2019Q4	irbt	Accrued Manufacturing And Logistics Costs AccruedManufacturingAndLogisticsCosts	14383000	USD
CY2021Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	17635000	USD
CY2019Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	13331000	USD
CY2021Q1	irbt	Accrued Sales Tax AccruedSalesTax	15480000	USD
CY2019Q4	irbt	Accrued Sales Tax AccruedSalesTax	12440000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6315000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6315000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6843000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3806000	USD
CY2019Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3378000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12144000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4996000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	131388000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81768000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	75000000.0	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000.0	USD
CY2021Q1	irbt	Interest Rate Above Libor Under Condition One InterestRateAboveLIBORUnderConditionOne	0.010
CY2021Q1	irbt	Interest Rate Abovethe Federal Fund Rate Under Condition Two InterestRateAbovetheFederalFundRateUnderConditionTwo	0.005
CY2021Q1	irbt	Interest Rate Abovethe Eurodollar Rate Under Condition Two InterestRateAbovetheEurodollarRateUnderConditionTwo	0.010
CY2021Q1	irbt	Letterofcreditfacilitymaximumborrowing Letterofcreditfacilitymaximumborrowing	5000000.0	USD
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	700000	USD
CY2021Q1	irbt	Lineofcreditmaximumamount Lineofcreditmaximumamount	220000000.0	JPY
CY2021	us-gaap	Revenues Revenues	1430390000	USD
CY2019	us-gaap	Revenues Revenues	1214010000	USD
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	1000000.0	USD
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	irbt	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1	vote
CY2018Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000.0	USD
CY2020Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000.0	USD
CY2020Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	663602	shares
CY2020Q2	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	37.65
CY2020Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	25000000.0	USD
CY2021Q1	irbt	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Plans SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfPlans	3	plan
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1750000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2495000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	745000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1562092	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30000000.0	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23700000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25800000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.55
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	127024	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	32.95
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29975000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23744000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25804000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	712954	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.34
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	239830	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	33.40
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10863	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	46.20
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	462261	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1938	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	45.89
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	10210000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	232116	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12329	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	37.03
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	322908	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.08
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	88292	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	31.40
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	232678	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10210000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	232678	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	36.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y9M
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	36.34
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10200000	USD
CY2021Q1	us-gaap	Share Price SharePrice	80.29
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2600000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8900000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14900000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	10000.00	USD
CY2021Q1	us-gaap	Share Price SharePrice	80.29
CY2021Q1	us-gaap	Share Price SharePrice	80.29
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate	0.15
CY2017Q2	irbt	Sharebased Compensation Arrangementby Sharebased Payment Award Maximum Amount SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumAmount	4000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	1000	shares
CY2021Q1	us-gaap	Contractual Obligation ContractualObligation	341900000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13856000	USD
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	11964000	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	11264000	USD
CY2021	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	28884000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	14091000	USD
CY2018	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	10798000	USD
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	18348000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	12199000	USD
CY2018	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	10098000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	24392000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13856000	USD
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	11964000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3000000.0	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2800000	USD
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	166973000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	84225000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	113078000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	20942000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	14608000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4456000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	187915000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	98833000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	108622000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13593000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13366000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	17627000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2724000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5004000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3676000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10451000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6941000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10732000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26768000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25311000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	32035000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14695000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9345000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2475000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2552000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1783000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1149000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3168000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-650000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7781000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14079000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11778000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11405000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40847000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13533000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20630000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	39462000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20755000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	22812000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4834000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3999000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4312000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	6702000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	8152000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	5638000	USD
CY2019Q4	irbt	Deferred Tax Liabilities Marketable Equity Securities DeferredTaxLiabilitiesMarketableEquitySecurities	0	USD
CY2021	irbt	Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Tax Benefits Related To Sharebased Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessTaxBenefitsRelatedToSharebasedCompensationAmount	-313000	USD
CY2019	irbt	Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Tax Benefits Related To Sharebased Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessTaxBenefitsRelatedToSharebasedCompensationAmount	6468000	USD
CY2018	irbt	Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Tax Benefits Related To Sharebased Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessTaxBenefitsRelatedToSharebasedCompensationAmount	6529000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	0	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	0	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	2127000	USD
CY2021	irbt	Effective Income Tax Rate Reconciliation Foreignderivedintangibleincomededuction EffectiveIncomeTaxRateReconciliationForeignderivedintangibleincomededuction	-3360000	USD
CY2019	irbt	Effective Income Tax Rate Reconciliation Foreignderivedintangibleincomededuction EffectiveIncomeTaxRateReconciliationForeignderivedintangibleincomededuction	-4180000	USD
CY2018	irbt	Effective Income Tax Rate Reconciliation Foreignderivedintangibleincomededuction EffectiveIncomeTaxRateReconciliationForeignderivedintangibleincomededuction	2678000	USD
CY2021	irbt	Effective Income Tax Rate Reconciliation Eme Abusinessrestructuring EffectiveIncomeTaxRateReconciliationEMEAbusinessrestructuring	0	USD
CY2019	irbt	Effective Income Tax Rate Reconciliation Eme Abusinessrestructuring EffectiveIncomeTaxRateReconciliationEMEAbusinessrestructuring	0	USD
CY2018	irbt	Effective Income Tax Rate Reconciliation Eme Abusinessrestructuring EffectiveIncomeTaxRateReconciliationEMEAbusinessrestructuring	2292000	USD
CY2021	irbt	Effective Income Tax Rate Reconciliation Executive Compensation EffectiveIncomeTaxRateReconciliationExecutiveCompensation	718000	USD
CY2019	irbt	Effective Income Tax Rate Reconciliation Executive Compensation EffectiveIncomeTaxRateReconciliationExecutiveCompensation	2081000	USD
CY2018	irbt	Effective Income Tax Rate Reconciliation Executive Compensation EffectiveIncomeTaxRateReconciliationExecutiveCompensation	745000	USD
CY2021	irbt	Effective Income Tax Rate Reconciliation Tax Impactof Foreign Earnings EffectiveIncomeTaxRateReconciliationTaxImpactofForeignEarnings	1458000	USD
CY2019	irbt	Effective Income Tax Rate Reconciliation Tax Impactof Foreign Earnings EffectiveIncomeTaxRateReconciliationTaxImpactofForeignEarnings	1986000	USD
CY2018	irbt	Effective Income Tax Rate Reconciliation Tax Impactof Foreign Earnings EffectiveIncomeTaxRateReconciliationTaxImpactofForeignEarnings	1336000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3817000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2678000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	348000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	307000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	834000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1503000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40847000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13533000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20630000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	20564000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	21355000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	14357000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	8225000	USD
CY2021Q1	irbt	Deferred Tax Asset Tax Deferred Expense Lease Liabilities DeferredTaxAssetTaxDeferredExpenseLeaseLiabilities	12429000	USD
CY2019Q4	irbt	Deferred Tax Asset Tax Deferred Expense Lease Liabilities DeferredTaxAssetTaxDeferredExpenseLeaseLiabilities	14117000	USD
CY2021Q1	irbt	Deferred Tax Liabilities Marketable Equity Securities DeferredTaxLiabilitiesMarketableEquitySecurities	10676000	USD
CY2021Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1700000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	12748000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	8814000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4868000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4981000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3793000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5068000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68759000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	62560000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7643000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3826000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	61116000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	58734000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3341000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3838000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	11443000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	13249000	USD
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3500000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7600000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2957000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	768000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	28417000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	17855000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	32699000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	40879000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3800000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1100000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7121000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7119000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4590000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	765000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	770000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2891000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1493000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1231000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	768000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	407000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2262000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	558000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8559000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7121000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7119000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9500000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Revenues Revenues	1430390000	USD
CY2019	us-gaap	Revenues Revenues	1214010000	USD
CY2018	us-gaap	Revenues Revenues	1092584000	USD
	us-gaap	Revenues Revenues	544827000	USD
CY2020Q3	us-gaap	Revenues Revenues	413145000	USD
CY2020Q2	us-gaap	Revenues Revenues	279883000	USD
CY2020Q1	us-gaap	Revenues Revenues	192535000	USD
CY2019Q4	us-gaap	Revenues Revenues	426778000	USD
CY2019Q3	us-gaap	Revenues Revenues	289399000	USD
CY2019Q2	us-gaap	Revenues Revenues	260172000	USD
CY2019Q1	us-gaap	Revenues Revenues	237661000	USD
	us-gaap	Gross Profit GrossProfit	215421000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	198841000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	178012000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	77955000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	169370000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	136841000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	118170000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	119546000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13335000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	22520000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	93252000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	58616000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-18135000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	20041000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	35532000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	7207000	USD
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.27
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.07
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.24
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78

Files In Submission

Name	View Source	Status
irbt-20210102_htm.xml	Edgar Link	completed
0001159167-21-000008-index-headers.html	Edgar Link	pending
0001159167-21-000008-index.html	Edgar Link	pending
0001159167-21-000008.txt	Edgar Link	pending
0001159167-21-000008-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
irbt-01022021x10kex211.htm	Edgar Link	pending
irbt-01022021x10kex231.htm	Edgar Link	pending
irbt-01022021x10kex311.htm	Edgar Link	pending
irbt-01022021x10kex312.htm	Edgar Link	pending
irbt-01022021x10kex321.htm	Edgar Link	pending
irbt-20210102.htm	Edgar Link	pending
irbt-20210102.xsd	Edgar Link	pending
irbt-20210102_cal.xml	Edgar Link	unprocessable
irbt-20210102_def.xml	Edgar Link	unprocessable
irbt-20210102_lab.xml	Edgar Link	unprocessable
irbt-20210102_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRBT
IROBOT CORP Stock $irbt

2021 Q1 Form 10-K Financial Statement

#000115916721000008 Filed on February 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT IROBOT CORP Stock $irbt

2021 Q1 Form 10-K Financial Statement

#000115916721000008 Filed on February 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT
IROBOT CORP Stock $irbt